Vimarsana
Biggest News Aggregation in the World

Thomas Lingelbach News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Lingelbach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Lingelbach Today - Breaking & Trending Today

Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum -January 04, 2024 at 11:46 am EST - Vimarsana News

Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum -January 04, 2024 at 11:46 am EST

Saint-Herblain , January 4, 2024 – Valneva SE , a specialty vaccine company, today announces that members of its management team including Thomas Lingelbach, CEO and Peter Bühler, CFO will hold...

21st Austria weekly - A1 Group, UBM, Valneva (20/12/2023) - Vimarsana News

21st Austria weekly - A1 Group, UBM, Valneva (20/12/2023)

21st Austria weekly - A1 Group UBM Valneva 20/12/2023 [pic1]A1 Group: The international rating agency Moody’s Investors Service Moody’s upgraded the credit of Group from Baa1 to A3 with a stable outlook earlier today. On top Standard & Poor’s and Fitch latest upgrade Moody's

Valneva: new governance system implemented -December 21, 2023 at 06:05 am EST - Vimarsana News

Valneva: new governance system implemented -December 21, 2023 at 06:05 am EST

Valneva announces that the resolutions recommended by its management board were approved by its combined AGM on December 20, including the immediate transition from a two-tier governance system to a...

Valneva SE (NASDAQ:VALN) Q3 2023 Earnings Call Transcript - Vimarsana News

Valneva SE (NASDAQ:VALN) Q3 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Valneva 9 Months 2023 Financial Results Call. [Operator Instructions].

Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® - Vimarsana News

Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ®

Saint-Herblain (France), November 10, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the...